Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -5.75% | -84.62% | 5.43 M USD | ||
| 4833 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 | XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +4.24% | +138.06% | 4.96 M USD | ||
| 4845 | NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -16.91% | -47.44% | 4.70 M USD | ||
| 4848 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -20.16% | +120.00% | 4.68 M USD | ||
| 4857 | ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 | DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -11.57% | -25.17% | 4.30 M USD | ||
| 4864 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 | ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -36.64% | +611.43% | 4.06 M USD | ||
| 4878 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -32.16% | -39.19% | 3.77 M USD | ||
| 4891 | GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -6.15% | -36.60% | 3.67 M USD | ||
| 4897 | EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 | SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -20.51% | -83.15% | 3.32 M USD | ||
| 4905 | APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -2.70% | -73.33% | 3.24 M USD | ||
| 4909 | REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -22.00% | -43.48% | 3.11 M USD | ||
| 4912 | MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 | MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -24.07% | -52.87% | 2.97 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表;ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日~15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |